Q4 2025 · 13F-HR
Resolute Capital Asset Partners LLCholdings as filed
Filed 2026-02-17 · accession 0001834913-26-000002
The Brief · Resolute Capital Asset Partners LLC · Q4 2025
AI · grounded in 13F
Resolute Capital Asset Partners LLC established a new position in Texas Pacific Land Corp TPL worth $13.07M. The fund also opened new stakes in Jazz Pharmaceuticals PLC and CRANE CO CR, while increasing its holdings in Andersons Inc ANDE by 1,200%. On the sell side, the fund closed its positions in Alibaba Group Holding Ltd BABA and Valvoline Inc VVV, reducing those holdings by $7.15M and $6.28M respectively.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 04351P101 | ASNDUSD | Ascendis Pharma A/S | $18.9M | 9.13% | 88,627 | Common | SOLE |
| 023135106 | AMZN | Amazon.Com Inc | $16.4M | 7.94% | 71,158 | Common | SOLE |
| 034164103 | ANDE | Andersons Inc | $13.8M | 6.68% | 260,000 | Common | SOLE |
| 88262P102 | TPL | Texas Pacific Land Corp | $13.1M | 6.31% | 45,500 | Common | SOLE |
| 02079K107 | GOOG | ALPHABET INC | $9.4M | 4.55% | 30,000 | Common | SOLE |
| 00370M103 | ABVX | Abivax Sa | $8.8M | 4.24% | 65,000 | Common | SOLE |
| 171757206 | CDTX | Cidara Therapeutics Inc | $8.2M | 3.98% | 37,315 | Common | SOLE |
| G50871105 | JAZZ | Jazz Pharmaceuticals PLC | $6.8M | 3.29% | 40,000 | Common | SOLE |
| 558868105 | MDGL | Madrigal Pharmaceuticals Inc | $6.4M | 3.07% | 10,918 | Common | SOLE |
| 883556102 | TMO | Thermo Fisher Scientific Inc | $5.8M | 2.80% | 10,000 | Common | SOLE |
| 224408104 | CR | CRANE CO | $5.5M | 2.67% | 30,000 | Common | SOLE |
| 808513105 | SCHW | Charles Schwab Corp | $5.5M | 2.65% | 55,000 | Common | SOLE |
| 871607107 | SNPS | Synopsys Inc | $4.7M | 2.27% | 10,000 | Common | SOLE |
| 235851102 | DHR | Danaher Corp | $4.6M | 2.21% | 20,000 | Common | SOLE |
| 377322102 | GKOS | Glaukos Corp | $4.6M | 2.21% | 40,500 | Common | SOLE |
| H11356104 | BG | Bunge Global Sa | $4.5M | 2.15% | 50,000 | Common | SOLE |
| 00187Y100 | APG | APi Group Corp | $4.4M | 2.13% | 115,000 | Common | SOLE |
| 000361105 | AIR | AAR Corp | $4.1M | 2.00% | 50,000 | Common | SOLE |
| 23282W605 | CYTK | Cytokinetics Inc | $4.1M | 2.00% | 65,000 | Common | SOLE |
| 629377508 | NRG | NRG Energy Inc | $4.0M | 1.92% | 25,000 | Common | SOLE |
| H2927K103 | AMRZ | Amrize Ag | $3.8M | 1.83% | 70,000 | Common | SOLE |
| 053332102 | AZO | Autozone Inc | $3.7M | 1.80% | 1,100 | Common | SOLE |
| 497266106 | KEX | Kirby Corp | $3.3M | 1.60% | 30,000 | Common | SOLE |
| 92840M102 | VST | Vistra Corp | $3.2M | 1.56% | 20,000 | Common | SOLE |
| 144285103 | CRS | Carpenter Technology Corp | $3.1M | 1.52% | 10,000 | Common | SOLE |
| 237266101 | DAR | Darling Ingredients Inc | $3.1M | 1.48% | 85,000 | Common | SOLE |
| 26884L109 | EQT | EQT Corp | $3.0M | 1.46% | 56,402 | Common | SOLE |
| 31847R102 | FAF | First American Financial Corp | $2.8M | 1.34% | 45,000 | Common | SOLE |
| 74340E103 | PGNY | Progyny Inc | $2.7M | 1.31% | 105,699 | Common | SOLE |
| 882508104 | TXN | Texas Instruments Inc | $2.6M | 1.26% | 15,000 | Common | SOLE |
| 913915104 | UTI | Universal Technical Institute Inc | $2.4M | 1.14% | 90,000 | Common | SOLE |
| 443510607 | HUBB | Hubbell Inc | $2.2M | 1.07% | 5,000 | Common | SOLE |
| G54950103 | LIN | Linde Plc | $2.1M | 1.03% | 5,000 | Common | SOLE |
| 023939101 | AMTM | Amentum Holdings Llc | $2.0M | 0.98% | 70,000 | Common | SOLE |
| 428291108 | HXL | Hexcel Corp | $1.9M | 0.90% | 25,100 | Common | SOLE |
| 76029N106 | REPL | Replimune Group Inc | $1.7M | 0.82% | 175,000 | Common | SOLE |
| 166764100 | CVX | Chevron Corp | $1.5M | 0.74% | 10,000 | Common | SOLE |
| 77311W101 | RKT | Rocket Companies Inc | $1.5M | 0.70% | 75,000 | Common | SOLE |
| 40609P105 | HNRG | Hallador Energy Co | $1.3M | 0.64% | 70,000 | Common | SOLE |
| 00510N102 | TIC | TIC Solutions Inc | $1.0M | 0.49% | 100,000 | Common | SOLE |
| 696389402 | PALI | Palisade Bio Inc | $940,000 | 0.45% | 400,000 | Common | SOLE |
| 98422E103 | XERS | Xeris Biopharma Holdings Inc | $785,000 | 0.38% | 100,000 | Common | SOLE |
| 05153U107 | AURA | Aura Biosciences Inc | $495,983 | 0.24% | 91,006 | Common | SOLE |
| 88080T104 | WULF | Terawulf Inc | $459,600 | 0.22% | 40,000 | Common | SOLE |
| 74907L409 | QNRX | Quoin Pharmaceuticals Ltd | $432,900 | 0.21% | 30,000 | Common | SOLE |
| 687604108 | ORKA | Oruka Therapeutics Inc | $378,875 | 0.18% | 12,500 | Common | SOLE |
| 85209E208 | SPRB | Spruce Biosciences Inc | $348,440 | 0.17% | 4,000 | Common | SOLE |
| 713317105 | PEPG | PepGen Inc | $325,500 | 0.16% | 50,000 | Common | SOLE |
| 00218A105 | ASPI | Asp Isotopes Inc | $267,500 | 0.13% | 50,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.